Xinjian Li, Ph.D, Prof.
-
Principal Investigator
Chinese Academy of Sciences Key Laboratory of Infection and Immunity, IBP
Research Interests: Metabolic reprogramming in innate immune response and tumorigenesis
Email: lixinjian@ibp.ac.cn
Tel: 010-64888557
Address: 15 Datun Road, Chaoyang District, Beijing, 100101, China
Chinese personal homepage
- Biography
2000 - 2004 Bachelor, South China Agricultural University
2004 - 2007 Master, South China University of Technology
2008 - 2009 Exchange Ph.D.student, National Cancer Centre Singapore
2007 - 2011 Ph.D., Sun Yat-sen University
2011 - 2016 Postdoctoral fellow, The University of Texas MD Anderson Cancer Center
2016 - 2019 Instructor, The University of Texas MD Anderson Cancer Center
2019 - Professor, Institute of Biophysics, Chinese Academy of Sciences
- Awards
2018 USCACA&AFCR Scholar Awards
2016 Caroline Ross Endowed Fellowship, The University of Texas MD Anderson Cancer Center
2016 The Harold C. and Mary L. Daily Endowment Fund Fellowship, The University of Texas MD Anderson Cancer Center
2015 The Anne Eastland Spears Fellowship in GI Cancer Research, The University of Texas MD Anderson Cancer Center
2013 - 2016 Odyssey Fellow,The University of Texas MD Anderson Cancer Center
- Membership in Academies & Societies
- Research Interests
Research Introduction
Metabolism is a combination of chemical reactions during life activity, cells may adjust their metabolism to adapt the extracellular environment, this process is referred as metabolic reprogramming. In mammals, innate immunity response, accompanied by metabolic reprogramming, is essential for the defense of pathogen invasion and clearance of intracellular damage. In addition, metabolic reprogramming is a key biological property of tumor cells comparing to heathy cells. Our lab focuses on identifying and characterizing the immunomodulatory functions of metabolic enzymes and metabolites, thus paving the way for the development of next generation therapeutics of anti-infection and anti-tumor.
Research Interests
1. Identifying the immunomodulatory metabolic enzymes and metabolites;
2. Unveiling the metabolic vulnerabilities in oncogene-driven cancers.
- Grants
- Selected Publications
(# First author, * corresponding author)
1. Chen C#, Liu CY#, Sun PK#, Zhang ZX, Wang ZM, Liu P, Li XJ*. Itaconate uptake via SLC13A3 improves hepatic antibacterial innate immunity. Developmental Cell 2024; doi: 10.1016/j.devcel.2024.07.011
2. Chen C#, Zhang ZX#, Liu CY#, Sun PK, Liu P, Li XJ*. ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis. Cell Metabolism 2024; 36(3): 498-510
3. Li X, Wang ZX, Chen C, Yang F, Liu P, Fang S, Wang B, Chen S*, Li XJ*. A small-molecule degrader selectively inhibits the growth of ALK-rearranged lung cancer with ceritinib resistance. iScience 2024; 27(2): 109015
4. Sun PK#, Zhang ZX#, Wang B, Liu CY, Chen C, Liu P, Li XJ*. A genetically encoded fluorescent biosensor for detecting itaconate with subcellular resolution in living macrophages. Nature Communications 2022; 13(1): 6562
5. Chen C#, Zhang ZX#, Liu CY, Wang B, Liu P, Fang S, Yang F, You YP, Li XJ*. ATF4-dependent fructolysis fuels growth of glioblastoma multiforme. Nature Communications 2022; 13(1): 6108
6. Zhang ZX#, Chen C#, Yang F, Zeng YX, Sun PK, Liu P, Li XJ*. Itaconate is a lysosomal inducer that promotes antibacterial innate immunity. Molecular Cell 2022; 82(15): 2844-2857
7. Zhang ZX#, Li X#, Yang F#, Chen C#, Liu P, Ren Y, Sun PK, Wang ZX, You YP, Zeng YX, Li XJ*. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nature Communications 2021; 12(1): 5872
(From Xinjian Li, September 13, 2024)